Effects of radium-223 dichloride (Ra-223) with docetaxel (D) versus D on prostate-specific antigen (PSA) and bone alkaline phosphatase (bALP) in patients (pts) with castration-resistant prostate cancer (CRPC) and bone metastases (mets): A phase 1/2a clinical trial Meeting Abstract

  

Authors:	Morris, M. J.; Higano, C. S.; Scher, H. I.; Sweeney, C.; Antonarakis, E. S.; Shevrin, D. H.; Ryan, C. J.; Lorlot, Y.; Fizazi, K.; Pandit-Taskar, N.; Garcia-Vargas, J. E.; Lyseng, K.; Bloma, M.; Aksnes, A. K.; Carrasquillo, J. A.
Abstract Title:	Effects of radium-223 dichloride (Ra-223) with docetaxel (D) versus D on prostate-specific antigen (PSA) and bone alkaline phosphatase (bALP) in patients (pts) with castration-resistant prostate cancer (CRPC) and bone metastases (mets): A phase 1/2a clinical trial
Meeting Title:	2015 Genitourinary Cancers Symposium
Journal Title:	Journal of Clinical Oncology
Volume:	33
Issue:	7 Suppl.
Meeting Dates:	2015 Feb 26-28
Meeting Location:	Orlando, FL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2015-03-01
Language:	English
ACCESSION:	WOS:000356886700203
PROVIDER:	wos
DOI:	10.1200/jco.2015.33.7_suppl.202
Notes:	Meeting Abstract: 202 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/77325